Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure

The risk posed by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study...

Full description

Bibliographic Details
Published in:Viruses
Main Authors: Emma K. Loveday, Kyle S. Hain, Irina Kochetkova, Jodi F. Hedges, Amanda Robison, Deann T. Snyder, Susan K. Brumfield, Mark J. Young, Mark A. Jutila, Connie B. Chang, Matthew P. Taylor
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/4/562